Clinical Trial Update: Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating trastuzumab plus docetaxel in women with recurrent or metastatic breast cancer has completed enrollment. The study status is reported…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED